Abstract:Polypills have been proven to improve the patient compliance to multi-drug treatment. However it is still poorly understood when the drugs of a polypill formulation are manufactured as a mixture. The formations of co-amorphous mixtures are one of the possible results of blending multiple drugs in a single process. This project investigated the co-amorphous mixtures of two model drugs, felodipine and paracetamol prepared by melt-cool method. The rationale of the model drug selections is based on the high interaction potentials (hydrogen bonding) between the two drugs as both contain hydrogen donors and acceptor groups. Three molar ratios of the co-amorphous systems of paracetamol and felodipine (P-F) were prepared and their physical stabilities were studied using SEM, DSC, ATR-FTIR and PXRD. It was noted that there is no clear intermolecular interaction between felodipine and paracetamol was identified. Higher paracetamol content led to poorer physical stability of the co-amorphous system which also led to hindered release of paracetamol. The dissolution rates of felodipine from the co-amorphous systems showed no significant improvement in comparison to crystalline felodipine indicating the rapid recrystallization of felodipine during the dissolution process. However the linear nearly zero order release of paracetamol indicated the entrapment of paracetamol in the recrystallized felodipine lattice. This confirmed the formation of co-amorphous mixture without specific hydrogen bonding between the two species. Soluplus was used as the polymeric excipient with an attempt to further improve the physical stability of the co-amorphous systems. The stability of P-F 1:1 loaded Soluplus HME extrudates showed significant improvement than the co-amorphous sample. However no significant dissolution enhancement was observed. This could be partially attributed to the use of the extrudates in the rod form instead of power form in the dissolution tests. Controlled release of paracetamol and poor dissolution of felodipine were obtained from the HME samples indicating the poor solubility enhancement capability of Soluplus in this formulation. The results of this project provided further understanding of the behaviour of co-amorphous system which non-specific interactions.

Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of N-(((1r,4r)-4-((6-fluorobenzo[d]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist

Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule

Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer

Improving the Chemical Stability of Amorphous Solid Dispersion with Cocrystal Technique by Hot Melt Extrusion

A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide

Thermodynamic aspects of the preparation of amorphous solid dispersions of Naringenin with enhanced dissolution rate

Preparation and evaluation of naproxen ternary solid dispersion using genetically modified cassava starch and hydroxypropyl methyl cellulose

Effect Of Polymeric Excipients On Nucleation And Crystal Growth Kinetics Of Amorphous Fluconazole

Drug-polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development.

Selection of Bionic Co-former Improves the Dissolution of Neohesperidin via Co-amorphous Solid Dispersion with Naringin

Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid–base neutralization approach

Poly (amino acid)s as new co-formers in amorphous solid dispersion

Enhancing the oral bioavailability of poorly water-soluble amisupiride with solid nanodispersion

Crystallization Kinetics and Molecular Dynamics of Binary Coamorphous Systems of Nimesulide and Profen Analogs

Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations

Development of Hot Melt Extruded Solid Dispersion Formulation for Stabilising Co-Amorphous Compounds

Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability

Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability

Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients

Powder Grinding Preparation of Co-Amorphous Β-Azelnidipine and Maleic Acid Combination: Molecular Interactions and Physicochemical Properties

High drug-loaded amorphous solid dispersions of a poor glass forming drug: The impact of polymer type and cooling rate on amorphous drug behaviour